Quest Diagnostics Incorporated

Quest Diagnostics Beats on EPS, Stock Down 1.5%

Quest Diagnostics reported an EPS of $1.76, beating expectations slightly. However, the stock reacted negatively, dropping 1.5%. Investors may be concerned about the lack of revenue data and guidance, which could contribute to uncertainty about the company's future performance.